Safechem Enterprises Private Limited sold 59,400 shares of Aarti Pharmalabs Limited for ₹5.20 Cr at ₹875.17 apiece, reducing its stake from 0.47% to 0.40%.
A pharmaceutical and nutraceutical manufacturer, Aarti Pharmalabs produces active pharmaceutical ingredients and finished dosage forms for domestic and international markets. The company specializes in contract manufacturing and custom synthesis services across multiple therapeutic segments including oncology, cardiology, and gastroenterology. Incorporated in 2019, it operates manufacturing facilities designed to meet stringent regulatory standards for pharmaceutical production and quality assurance.
Get the next move the moment it happens.
Follow the investors and Aarti Pharmalabs Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.